Literature DB >> 28004300

Effect of Wenhua Juanbi Recipe () on expression of receptor activator of nuclear factor kappa B ligand, osteoprotegerin, and tumor necrosis factor receptor superfamily member 14 in rats with collagen-induced arthritis.

Xi-de Liu1, Yun-Qing Wang2, Long Cai3, Li-Hong Ye3, Fang Wang2, Ying-Ying Feng2.   

Abstract

OBJECTIVES: To study the effect of Wenhua Juanbi Recipe (, WJR) on expression of receptor activator of nuclear factor kappa B ligand (RANKL), osteoprotegerin (OPG), and tumor necrosis factor receptor superfamily member 14 (TNFRSF14, also known as LIGHT) in rats with collagen-induced arthritis (CIA).
METHODS: CIA rats were generated by subcutaneous injection of bovine collagen type-II at the tail base. Sixty CIA rats were randomly assigned (10 animals/group) to: model, methotrexate (MTX)-treated (0.78 mg/kg body weight), and WJR-treated (22.9 g/kg) groups. Healthy normal rats (n=10) were used as the normal control. Treatments or saline were administered once daily by oral gavage. Rats were sacrifificed at day 28 post-treatment and knee synovium and peripheral blood serum were collected. Toe swelling degree and expression of RANKL, OPG, and LIGHT were determined by Western blot and immunohistochemistry.
RESULTS: Compared with the normal group, toe swelling degree was signifificantly increased in the model group (P<0.01). After treatment, toe swelling degree decreased signifificantly in the WJR and MTX groups compared with the model group (P<0.01). Compared with the normal group, expression of RANKL and LIGHT were signifificantly increased and OPG signifificantly decreased in peripheral blood and synovium of the model group (P<0.01). Conversely, RANKL and LIGHT expression were signifificantly reduced and OPG increased in the WJR and MTX groups compared with the model group (P<0.01). No statistically significant difference existed between WJR and MTX groups.
CONCLUSION: WJR likely acts by reducing RANKL expression and increasing OPG expression, thus inhibiting RANKL/RANK interaction and reducing LIGHT expression, thereby inhibiting osteoclast formation/activation to block bone erosion.

Entities:  

Keywords:  Chinese medicine; Wenhua Juanbi Recipe; collagen-induced arthritis; osteoprotegerin; peripheral blood; receptor activator of nuclear factor kappa B ligand; synovium; tumor necrosis factor receptor superfamily member 14

Mesh:

Substances:

Year:  2016        PMID: 28004300     DOI: 10.1007/s11655-016-2532-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  13 in total

1.  Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

Authors:  R A Carter; I K Campbell; K L O'Donnel; I P Wicks
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 3.  [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG].

Authors:  Nobuhiro Sasaki; Eiji Kusano
Journal:  Clin Calcium       Date:  2006-06

Review 4.  Osteoclasts, rheumatoid arthritis, and osteoimmunology.

Authors:  Kojiro Sato; Hiroshi Takayanagi
Journal:  Curr Opin Rheumatol       Date:  2006-07       Impact factor: 5.006

5.  LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.

Authors:  J R Edwards; S G Sun; R Locklin; C M Shipman; I E Adamopoulos; N A Athanasou; A Sabokbar
Journal:  Arthritis Rheum       Date:  2006-05

6.  Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.

Authors:  Georg Schett; Scot Middleton; Brad Bolon; Marina Stolina; Heather Brown; Li Zhu; Jim Pretorius; Debra J Zack; Paul Kostenuik; Ulrich Feige
Journal:  Arthritis Rheum       Date:  2005-05

7.  Effect of Wenhua Juanbi recipe on proliferation and apoptosis of synoviocytes in rats with collagen-inducing arthritis.

Authors:  Xi-de Liu; Ying Chen; Feng-yun Liu; Li-hong Ye; Long Cai
Journal:  Chin J Integr Med       Date:  2011-06-29       Impact factor: 1.978

Review 8.  [RANKL as a target molecule for treatment of joint destruction].

Authors:  Sakae Tanaka
Journal:  Clin Calcium       Date:  2007-04

Review 9.  Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.

Authors:  Brendan F Boyce; Edward M Schwarz; Lianping Xing
Journal:  Curr Opin Rheumatol       Date:  2006-07       Impact factor: 5.006

10.  Resistance to collagen-induced arthritis in SHPS-1 mutant mice.

Authors:  Chie Okuzawa; Yoriaki Kaneko; Yoji Murata; Astuko Miyake; Yasuyuki Saito; Jun Okajo; Takeshi Tomizawa; Yuka Kaneko; Hideki Okazawa; Hiroshi Ohnishi; Takashi Matozaki; Yoshihisa Nojima
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

View more
  1 in total

1.  Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes.

Authors:  Wan-Tai Dang; Wen-Guang Xie; Jing-Guo Zhou
Journal:  Chin J Integr Med       Date:  2017-10-30       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.